Atlas Trials

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

Clinical trial NCT05633810 · RECRUITING

Trial details

NCT number
NCT05633810
Sponsor
Montreal Heart Institute
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Diabete Type 2Cardiovascular Diseases
Start date
2022-12-21
Primary completion
2027-12-01
Enrollment
10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.